Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME).
| Target |
Preferentially Expressed Antigen In Melanoma (PRAME) |
| Reactivity |
Human |
| Clonality |
Polyclonal |
| Tested Applications |
WB, IHC, IF/ICC, IP |
| Recommended dilutions |
WB: 0.2-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Immunogen |
PRAME (Asn416-Leu502) |
| Purification |
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Form |
Liquid |
| Isotype |
IgG |
| Conjugation |
Unconjugated |
| Specificity |
The antibody is a rabbit polyclonal antibody raised against PRAME. It has been selected for its ability to recognize PRAME in immunohistochemical staining and western blotting. |
| Storage |
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Swiss Prot |
P78395
|
| Buffer |
PBS, pH 7.4, containing 0.01% Sarkosyl, 1 mM DTT, 5% Trehalose and Proclin-300. |
| UNSPSC Code |
12352203 |
| Availability |
Shipped within 5-7 working days. |
| Note |
This product is for research use only. |